Tashbib Khan
37 Kent Street
Woolloongabba, QLD, Australia
Woolloongabba, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Pathogenic OTUD3 Mutations Predispose to Ulcerative Colitis Due to Barrier Dysfunction.
Journal: Cellular and molecular gastroenterology and hepatology
Published: May 14, 2025
Receptor CDCP1 Is a Potential Target for Personalized Imaging and Treatment of Poor Outcome HER2+, Triple-Negative, and Metastatic ER+/HER2- Breast Cancers.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 04, 2024
CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapy.
Journal: Theranostics
Published: August 19, 2022
Preclinical Evaluation of a Fluorescent Probe Targeting Receptor CDCP1 for Identification of Ovarian Cancer.
Journal: Molecular pharmaceutics
Published: August 27, 2021
Preclinical Molecular PET-CT Imaging Targeting CDCP1 in Colorectal Cancer.
Journal: Contrast media & molecular imaging
Published: July 02, 2021
Substrate-biased activity-based probes identify proteases that cleave receptor CDCP1.
Journal: Nature chemical biology
Published: October 14, 2020
The CDCP1 Signaling Hub: A Target for Cancer Detection and Therapeutic Intervention.
Journal: Cancer research
Published: September 01, 2020
Revisiting Glycogen in Cancer: A Conspicuous and Targetable Enabler of Malignant Transformation.
Journal: Frontiers in oncology
Published: August 07, 2020
Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma.
Journal: Cancers
Published: March 10, 2020
Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer.
Journal: Theranostics
Published: October 16, 2018
Last Updated: 09/26/2026